Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04291105
Title Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vyriad, Inc.

hepatocellular carcinoma

endometrial adenocarcinoma

lung non-small cell carcinoma



Cemiplimab + VSV-hIFNbeta-NIS

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.